Literature DB >> 29038213

Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus".

Lawrence H Young1, Catherine M Viscoli1, Silvio E Inzucchi1, Walter N Kernan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29038213      PMCID： PMC5683402          DOI： 10.1161/CIRCULATIONAHA.117.030513

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus.

Authors:  Lawrence H Young; Catherine M Viscoli; Jeptha P Curtis; Silvio E Inzucchi; Gregory G Schwartz; Anne M Lovejoy; Karen L Furie; Mark J Gorman; Robin Conwit; J Dawn Abbott; Daniel L Jacoby; Daniel M Kolansky; Steven E Pfau; Frederick S Ling; Walter N Kernan
Journal:  Circulation       Date:  2017-02-28       Impact factor: 29.690

2.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

3.  Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Daniel T Lackland; Mitchell S V Elkind; Ralph D'Agostino; Mandip S Dhamoon; David C Goff; Randall T Higashida; Leslie A McClure; Pamela H Mitchell; Ralph L Sacco; Cathy A Sila; Sidney C Smith; David Tanne; David L Tirschwell; Emmanuel Touzé; Lawrence R Wechsler
Journal:  Stroke       Date:  2012-05-24       Impact factor: 7.914

4.  Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.

Authors:  Kenneth Cusi; Beverly Orsak; Fernando Bril; Romina Lomonaco; Joan Hecht; Carolina Ortiz-Lopez; Fermin Tio; Jean Hardies; Celia Darland; Nicolas Musi; Amy Webb; Paola Portillo-Sanchez
Journal:  Ann Intern Med       Date:  2016-06-21       Impact factor: 25.391

5.  Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study.

Authors:  G J Hankey; K Jamrozik; R J Broadhurst; S Forbes; P W Burvill; C S Anderson; E G Stewart-Wynne
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

6.  Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.

Authors:  Mark A Deeg; John B Buse; Ronald B Goldberg; David M Kendall; Anthony J Zagar; Scott J Jacober; Mehmood A Khan; Alfonzo T Perez; Meng H Tan
Journal:  Diabetes Care       Date:  2007-06-26       Impact factor: 19.112

7.  Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Authors:  Walter N Kernan; Catherine M Viscoli; Karen L Furie; Lawrence H Young; Silvio E Inzucchi; Mark Gorman; Peter D Guarino; Anne M Lovejoy; Peter N Peduzzi; Robin Conwit; Lawrence M Brass; Gregory G Schwartz; Harold P Adams; Leo Berger; Antonio Carolei; Wayne Clark; Bruce Coull; Gary A Ford; Dawn Kleindorfer; John R O'Leary; Mark W Parsons; Peter Ringleb; Souvik Sen; J David Spence; David Tanne; David Wang; Toni R Winder
Journal:  N Engl J Med       Date:  2016-02-17       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.